Neoplasms benign, malignant and unspecified (incl cysts and polyps) – page 152

Study of Anti-GD2-800CW for Imaging in Children with Neuroblastoma

Study of Anti-GD2-800CW for Imaging in Children with Neuroblastoma

Study on Imaging Head and Neck Cancer Using [18F]-Olaparib for Patients with Squamous Cell Carcinoma

Study on Imaging Head and Neck Cancer Using [18F]-Olaparib for Patients with Squamous Cell Carcinoma

Study on the Safety and Effectiveness of CEB-01 for Children with Resectable Tumors

Study on the Safety and Effectiveness of CEB-01 for Children with Resectable Tumors

Study of Loncastuximab Tesirine and Epcoritamab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma, High-grade B-cell Lymphoma, or Follicular Lymphoma Grade 3B

Study of Loncastuximab Tesirine and Epcoritamab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma, High-grade B-cell Lymphoma, or Follicular Lymphoma Grade 3B

Study on the Effects of INT230-6, Vinblastine Sulfate, and Cisplatin in Patients with Early Triple-Negative Breast Cancer

Study on the Effects of INT230-6, Vinblastine Sulfate, and Cisplatin in Patients with Early Triple-Negative Breast Cancer

Study on Relugolix and Radiation Therapy for Patients with Intermediate Risk Prostate Cancer

Study on Relugolix and Radiation Therapy for Patients with Intermediate Risk Prostate Cancer

Study of IOMX-0675 alone or combined with pembrolizumab for patients with previously treated advanced or metastatic solid tumors

Study of 5-Fluorouracil, Panitumumab, and Sotorasib for Patients with Advanced KRAS G12C Mutated Colorectal Cancer Not Eligible for Standard Chemotherapy

Study of 5-Fluorouracil, Panitumumab, and Sotorasib for Patients with Advanced KRAS G12C Mutated Colorectal Cancer Not Eligible for Standard Chemotherapy

Study of Cabozantinib for Patients with Non-Small Cell Lung Cancer and MET Deregulation

Study of Cabozantinib for Patients with Non-Small Cell Lung Cancer and MET Deregulation

Study on Datopotamab Deruxtecan and Rilvegostomig for Stage I Non-Small Cell Lung Cancer Patients with ctDNA-Positive or High-Risk Features

Study on Datopotamab Deruxtecan and Rilvegostomig for Stage I Non-Small Cell Lung Cancer Patients with ctDNA-Positive or High-Risk Features

Study of Nivolumab and Ipilimumab or Drug Combination for Patients with Metastatic Kidney Cancer

Study of Nivolumab and Ipilimumab or Drug Combination for Patients with Metastatic Kidney Cancer

Study Comparing Fosfomycin and Ciprofloxacin for Preventing Fever in Patients with Acute Leukemia After Chemotherapy or Stem Cell Transplant

Study Comparing Fosfomycin and Ciprofloxacin for Preventing Fever in Patients with Acute Leukemia After Chemotherapy or Stem Cell Transplant